New biologic combo shows promise for lupus kidney patients
Disease control
Recruiting now
This study tests whether newer biologic drugs (belimumab or telitacicept) can control active lupus kidney disease better than the standard treatment. About 50 adults with biopsy-confirmed lupus nephritis will receive either a biologic plus steroids, standard therapy (mycophenolat…
Phase: PHASE2 • Sponsor: Nanjing University School of Medicine • Aim: Disease control
Last updated May 22, 2026 14:02 UTC